Logo image of EPAM

EPAM SYSTEMS INC (EPAM) Stock Fundamental Analysis

USA - NYSE:EPAM - US29414B1044 - Common Stock

154.57 USD
+0.02 (+0.01%)
Last: 9/16/2025, 8:14:27 PM
154.88 USD
+0.31 (+0.2%)
After Hours: 9/16/2025, 8:14:27 PM
Fundamental Rating

6

Taking everything into account, EPAM scores 6 out of 10 in our fundamental rating. EPAM was compared to 86 industry peers in the IT Services industry. EPAM has an excellent financial health rating, but there are some minor concerns on its profitability. EPAM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

EPAM had positive earnings in the past year.
EPAM had a positive operating cash flow in the past year.
EPAM had positive earnings in each of the past 5 years.
Each year in the past 5 years EPAM had a positive operating cash flow.
EPAM Yearly Net Income VS EBIT VS OCF VS FCFEPAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

EPAM has a better Return On Assets (8.52%) than 80.23% of its industry peers.
EPAM's Return On Equity of 10.94% is fine compared to the rest of the industry. EPAM outperforms 67.44% of its industry peers.
With a decent Return On Invested Capital value of 10.85%, EPAM is doing good in the industry, outperforming 75.58% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EPAM is significantly below the industry average of 21.79%.
Industry RankSector Rank
ROA 8.52%
ROE 10.94%
ROIC 10.85%
ROA(3y)9.87%
ROA(5y)11.06%
ROE(3y)12.84%
ROE(5y)14.88%
ROIC(3y)11.98%
ROIC(5y)12.84%
EPAM Yearly ROA, ROE, ROICEPAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 7.91%, EPAM is doing good in the industry, outperforming 74.42% of the companies in the same industry.
In the last couple of years the Profit Margin of EPAM has declined.
EPAM's Operating Margin of 10.91% is fine compared to the rest of the industry. EPAM outperforms 72.09% of its industry peers.
EPAM's Operating Margin has declined in the last couple of years.
EPAM's Gross Margin of 30.05% is on the low side compared to the rest of the industry. EPAM is outperformed by 62.79% of its industry peers.
EPAM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.91%
PM (TTM) 7.91%
GM 30.05%
OM growth 3Y-7.24%
OM growth 5Y-2.7%
PM growth 3Y-9.14%
PM growth 5Y-3.32%
GM growth 3Y-3.28%
GM growth 5Y-2.67%
EPAM Yearly Profit, Operating, Gross MarginsEPAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EPAM is creating some value.
EPAM has less shares outstanding than it did 1 year ago.
EPAM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EPAM has an improved debt to assets ratio.
EPAM Yearly Shares OutstandingEPAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EPAM Yearly Total Debt VS Total AssetsEPAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 7.53 indicates that EPAM is not in any danger for bankruptcy at the moment.
EPAM has a Altman-Z score of 7.53. This is amongst the best in the industry. EPAM outperforms 88.37% of its industry peers.
The Debt to FCF ratio of EPAM is 0.06, which is an excellent value as it means it would take EPAM, only 0.06 years of fcf income to pay off all of its debts.
EPAM's Debt to FCF ratio of 0.06 is amongst the best of the industry. EPAM outperforms 95.35% of its industry peers.
EPAM has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EPAM (0.01) is better than 83.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.06
Altman-Z 7.53
ROIC/WACC1.19
WACC9.14%
EPAM Yearly LT Debt VS Equity VS FCFEPAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 3.17 indicates that EPAM has no problem at all paying its short term obligations.
EPAM's Current ratio of 3.17 is amongst the best of the industry. EPAM outperforms 81.40% of its industry peers.
EPAM has a Quick Ratio of 3.17. This indicates that EPAM is financially healthy and has no problem in meeting its short term obligations.
EPAM has a better Quick ratio (3.17) than 81.40% of its industry peers.
Industry RankSector Rank
Current Ratio 3.17
Quick Ratio 3.17
EPAM Yearly Current Assets VS Current LiabilitesEPAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

EPAM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.22%.
The Earnings Per Share has been growing by 14.89% on average over the past years. This is quite good.
Looking at the last year, EPAM shows a quite strong growth in Revenue. The Revenue has grown by 9.73% in the last year.
The Revenue has been growing by 15.56% on average over the past years. This is quite good.
EPS 1Y (TTM)7.22%
EPS 3Y6.34%
EPS 5Y14.89%
EPS Q2Q%13.06%
Revenue 1Y (TTM)9.73%
Revenue growth 3Y7.95%
Revenue growth 5Y15.56%
Sales Q2Q%18.04%

3.2 Future

EPAM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.94% yearly.
EPAM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.84% yearly.
EPS Next Y3.88%
EPS Next 2Y7.19%
EPS Next 3Y8.3%
EPS Next 5Y8.94%
Revenue Next Year15.25%
Revenue Next 2Y11.11%
Revenue Next 3Y10.42%
Revenue Next 5Y9.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EPAM Yearly Revenue VS EstimatesEPAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EPAM Yearly EPS VS EstimatesEPAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.88, which indicates a correct valuation of EPAM.
EPAM's Price/Earnings ratio is rather cheap when compared to the industry. EPAM is cheaper than 81.40% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, EPAM is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 12.38, the valuation of EPAM can be described as correct.
EPAM's Price/Forward Earnings ratio is rather cheap when compared to the industry. EPAM is cheaper than 82.56% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, EPAM is valued a bit cheaper.
Industry RankSector Rank
PE 13.88
Fwd PE 12.38
EPAM Price Earnings VS Forward Price EarningsEPAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

EPAM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EPAM is cheaper than 72.09% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EPAM is valued a bit cheaper than 67.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.01
EV/EBITDA 10.54
EPAM Per share dataEPAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EPAM does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.57
PEG (5Y)0.93
EPS Next 2Y7.19%
EPS Next 3Y8.3%

0

5. Dividend

5.1 Amount

No dividends for EPAM!.
Industry RankSector Rank
Dividend Yield N/A

EPAM SYSTEMS INC

NYSE:EPAM (9/16/2025, 8:14:27 PM)

After market: 154.88 +0.31 (+0.2%)

154.57

+0.02 (+0.01%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners94.25%
Inst Owner Change-1.14%
Ins Owners3.54%
Ins Owner Change1.86%
Market Cap8.61B
Analysts80.83
Price Target217.09 (40.45%)
Short Float %3.81%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.02%
Min EPS beat(2)3.97%
Max EPS beat(2)4.07%
EPS beat(4)4
Avg EPS beat(4)5.61%
Min EPS beat(4)1.07%
Max EPS beat(4)13.33%
EPS beat(8)8
Avg EPS beat(8)5.66%
EPS beat(12)12
Avg EPS beat(12)7.23%
EPS beat(16)16
Avg EPS beat(16)10.93%
Revenue beat(2)0
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)-0.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)0.84%
Revenue beat(8)1
Avg Revenue beat(8)-0.68%
Revenue beat(12)2
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)0.24%
PT rev (1m)-2.11%
PT rev (3m)-2.14%
EPS NQ rev (1m)1.63%
EPS NQ rev (3m)3.6%
EPS NY rev (1m)2.08%
EPS NY rev (3m)2.35%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.04%
Valuation
Industry RankSector Rank
PE 13.88
Fwd PE 12.38
P/S 1.7
P/FCF 21.01
P/OCF 19.15
P/B 2.35
P/tB 4.26
EV/EBITDA 10.54
EPS(TTM)11.14
EY7.21%
EPS(NY)12.49
Fwd EY8.08%
FCF(TTM)7.36
FCFY4.76%
OCF(TTM)8.07
OCFY5.22%
SpS91.04
BVpS65.85
TBVpS36.31
PEG (NY)3.57
PEG (5Y)0.93
Profitability
Industry RankSector Rank
ROA 8.52%
ROE 10.94%
ROCE 13.96%
ROIC 10.85%
ROICexc 14.72%
ROICexgc 33.69%
OM 10.91%
PM (TTM) 7.91%
GM 30.05%
FCFM 8.08%
ROA(3y)9.87%
ROA(5y)11.06%
ROE(3y)12.84%
ROE(5y)14.88%
ROIC(3y)11.98%
ROIC(5y)12.84%
ROICexc(3y)23.91%
ROICexc(5y)27.45%
ROICexgc(3y)44.54%
ROICexgc(5y)48.5%
ROCE(3y)15.42%
ROCE(5y)16.54%
ROICexcg growth 3Y-11.88%
ROICexcg growth 5Y3.29%
ROICexc growth 3Y-20.35%
ROICexc growth 5Y-8.92%
OM growth 3Y-7.24%
OM growth 5Y-2.7%
PM growth 3Y-9.14%
PM growth 5Y-3.32%
GM growth 3Y-3.28%
GM growth 5Y-2.67%
F-Score6
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.06
Debt/EBITDA 0.03
Cap/Depr 23.85%
Cap/Sales 0.79%
Interest Coverage 250
Cash Conversion 62.42%
Profit Quality 102.14%
Current Ratio 3.17
Quick Ratio 3.17
Altman-Z 7.53
F-Score6
WACC9.14%
ROIC/WACC1.19
Cap/Depr(3y)45.04%
Cap/Depr(5y)75.64%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.71%
Profit Quality(3y)111.75%
Profit Quality(5y)115.25%
High Growth Momentum
Growth
EPS 1Y (TTM)7.22%
EPS 3Y6.34%
EPS 5Y14.89%
EPS Q2Q%13.06%
EPS Next Y3.88%
EPS Next 2Y7.19%
EPS Next 3Y8.3%
EPS Next 5Y8.94%
Revenue 1Y (TTM)9.73%
Revenue growth 3Y7.95%
Revenue growth 5Y15.56%
Sales Q2Q%18.04%
Revenue Next Year15.25%
Revenue Next 2Y11.11%
Revenue Next 3Y10.42%
Revenue Next 5Y9.84%
EBIT growth 1Y11.21%
EBIT growth 3Y0.14%
EBIT growth 5Y12.45%
EBIT Next Year14.6%
EBIT Next 3Y12.62%
EBIT Next 5Y11.07%
FCF growth 1Y-26.81%
FCF growth 3Y4.58%
FCF growth 5Y22.87%
OCF growth 1Y-26.87%
OCF growth 3Y-0.77%
OCF growth 5Y14.23%